EXPAREL (Pacira Pharmaceuticals Inc.)


Welcome to the PulseAid listing for the EXPAREL drug offered from Pacira Pharmaceuticals Inc.. This Amide Local Anesthetic [EPC],Amides [Chemical/Ingredient],Local Anesthesia [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Pacira Pharmaceuticals Inc.
NON-PROPRIETARY NAME: bupivacaine
SUBSTANCE NAME: BUPIVACAINE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Amide Local Anesthetic [EPC],Amides [Chemical/Ingredient],Local Anesthesia [PE]
ROUTE: INFILTRATION
DOSAGE FORM: INJECTION, SUSPENSION, LIPOSOMAL
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2016-01-01
END MARKETING DATE: 0000-00-00


EXPAREL HUMAN PRESCRIPTION DRUG Details:

Item DescriptionEXPAREL from Pacira Pharmaceuticals Inc.
LABELER NAME: Pacira Pharmaceuticals Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 13.3(mg/mL)
START MARKETING DATE: 2016-01-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 65250-133_a0d004eb-0186-4e2f-9fec-f202f49b46cc
PRODUCT NDC: 65250-133
APPLICATION NUMBER: NDA022496

Other BUPIVACAINE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Pacira Pharmaceuticals Inc.EXPAREL